in_vitro_activities
Differences
This shows you the differences between two versions of the page.
| Both sides previous revisionPrevious revision | |||
| in_vitro_activities [2026/01/17 10:31] – renefeyereisen | in_vitro_activities [2026/02/18 16:20] (current) – renefeyereisen | ||
|---|---|---|---|
| Line 35: | Line 35: | ||
| ^CYP306A1|Mamestra brassicae|D: | ^CYP306A1|Mamestra brassicae|D: | ||
| ^CYP306A1|Helicoverpa armigera|B: ethoxycoumarin, | ^CYP306A1|Helicoverpa armigera|B: ethoxycoumarin, | ||
| + | ^CYP306A1|Bemisia tabaci|B: imidacloprid|Liu et al., 2023| | ||
| + | ^CYP306A1|Bemisia tabaci|B: imidacloprid|Liu et al., 2025| | ||
| ^CYP306A2 (2? | ^CYP306A2 (2? | ||
| ^CYP307A2 (wrongly called 307A1)|Helicoverpa armigera|B: BOMR|Shi et al. 2022| | ^CYP307A2 (wrongly called 307A1)|Helicoverpa armigera|B: BOMR|Shi et al. 2022| | ||
| Line 426: | Line 428: | ||
| ^CYP417A2v2|Laodelphax striatellus|B: | ^CYP417A2v2|Laodelphax striatellus|B: | ||
| ^CYP425A1|Nilaparvata lugens|B: etofenprox to 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzoate (ester metabolite) |Zhang et al., 2026| | ^CYP425A1|Nilaparvata lugens|B: etofenprox to 2-(4-ethoxyphenyl)-2-methylpropyl 3-phenoxybenzoate (ester metabolite) |Zhang et al., 2026| | ||
| + | ^CYP426A1|Laodelphax striatellus|B: | ||
| ^CYP439A1v3|Laodelphax striatellus|B: | ^CYP439A1v3|Laodelphax striatellus|B: | ||
| ^CYP439A1|Nilaparvata lugens|buprofezin|Zeng et al.2023| | ^CYP439A1|Nilaparvata lugens|buprofezin|Zeng et al.2023| | ||
in_vitro_activities.txt · Last modified: by renefeyereisen
